article Open AccessTop 1% cited

Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer

European Urology · 2014 · Vol. 67(1) · pp. 33–41

Xiaoyi Huang(Medical College of Wisconsin)Tiezheng Yuan(Medical College of Wisconsin)Meihua Liang(Harbin Medical University)Meijun Du(Medical College of Wisconsin)Shu Xia(Tongji Hospital)Rachel L. Dittmar(Medical College of Wisconsin)Dian Wang(Medical College of Wisconsin)William A. See(Medical College of Wisconsin)Brian A. Costello(Mayo Clinic in Arizona)Fernando Quevedo(Mayo Clinic in Arizona)Winston Tan(WinnMed)Debashis Nandy(Mayo Clinic in Arizona)Graham H. Bevan(University of Rochester Medical Center)Sherri Longenbach(Mayo Clinic in Arizona)Zhifu Sun(Mayo Clinic)Yan Lü(Medical College of Wisconsin)Tao Wang(Medical College of Wisconsin)Stephen N. Thibodeau(Mayo Clinic in Arizona)Lisa A. Boardman(Mayo Clinic in Arizona)Manish Kohli✉(Mayo Clinic in Arizona)Liang Wang(Medical College of Wisconsin)

View via DOI Publisher page

Extracellular vesicles in disease Prostate Cancer Treatment and Research MicroRNA in disease regulationMedicineProstate cancerOncologyProportional hazards modelmicroRNAInternal medicineCohortSurvival analysisMicrovesiclesCancer

MeSH terms

AdultAgedAged, 80 and overHumansMaleMiddle AgedPrognosisBiomarkers, TumorSurvival RateProportional Hazards ModelsMicroRNAsKaplan-Meier EstimateExosomesProstatic Neoplasms, Castration-Resistant

Citations

696

FWCI

20.36

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis